Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...

Democratic members of Congress demanded answers about Homeland Security's vetting and training of immigration enforcement ...

The mayor issued a statement in response to Adam Silver's concerns that appear to be about the pace and tenor of negotiations ...

Nature Medicine today featured on its cover the findings from The Feinstein Institutes for Medical Research, demonstrating ...

The crew was rescued after the close call. Meanwhile, blazes in Canada have left Toronto under a haze and smoke heading ...

Trump's comments aired as the two countries exchanged fire for the fourth day in a row and the US resumed blockading Iranian ...

David Cameron addressed MPs on the reasons behind his EU veto Deputy PM Nick Clegg says the decision was "bad for Britain" Labour say Mr Cameron mishandled the negotiations and has left Britain ...